ADM has been named a winner in the 2021 BIG Innovation awards presented by the Business Intelligence Group.
The company’s probiotic strain, Bifidobacterium lactis (BPL1), was featured among the 2021 winning products in the food and beverage category.
“We’re very pleased to be recognized by the BIG Innovation Awards for our continued advancements in the field of microbiome science,” said Ian Pinner, Chief Strategy and Innovation Officer, and President of ADM’s Health & Wellness division. “Today’s consumers face unprecedented health and wellness challenges, and we are committed to delivering leading-edge microbiome research and innovation to help our customers provide science-backed metabolic health solutions in a wide range of convenient, consumer-friendly applications.”
BPL1 targets metabolic health through body mass index (BMI) reduction with an impact on waist circumference and abdominal fat. BPL1 is available as a live probiotic and also as a heat-treated postbiotic that retains functional properties for waist circumference reduction and impacting abdominal fat.
As a postbiotic (i.e., when heat-treated), the product has potential for application across various food and beverage products, from sports drinks and bars to dairy products, including ice cream. This flexibility makes probiotics more easily accessible to the masses, ADM says.
“More than ever, the global society relies on innovation to help progress humanity and make our lives more productive, healthy and comfortable,” said Maria Jimenez, COO of the Business Intelligence Group. “We are thrilled to be honouring ADM as they are one of the organizations leading this charge and helping humanity progress.”
In addition to this recognition, BPL1 was Ingredient of the Year for NutraIngredients’ Weight Management category in 2020.
